Skip to content
  • Argentina
  • Brazil
  • Canada
  • Chile
  • China
  • Colombia
  • Europe
  • France
  • Germany
  • India
  • Italy
  • Japan
  • Korea
  • Mexico
  • Perú
  • Russia
  • Spain
  • Taiwan
  • The Middle East
  • Turkey
  • United Kingdom
  • United States
  • Vietnam
  • We guide you
    • Fertility
    • Healthy Pregnancy
  • Reproductive Health
    • Specialists
      • ERA
      • EndomeTRIO
      • EMMA
      • ALICE
      • CGT
      • PGT-A
      • EMBRACE
      • PGT-M
      • NACE
      • POC
      • SAT
    • Patients
      • ERA
      • EndomeTRIO
      • EMMA
      • ALICE
      • CGT
      • PGT-A
      • EMBRACE
      • PGT-M
      • NACE
      • POC
      • SAT
  • Kit Request
  • About us
    • Igenomix Research
    • About Igenomix
  • Academy
  • Webinars
  • Blog
  • +1 (905) 565-9495 Request Information
  • French
Genetic Solutions > SAT

SAT Sperm aneuploidy test

Analysis of sperm chromosomal abnormalities

  • Technical Overview
  • Documentation
  • Scientific evidence
  • I’m not a health specialist

Up to 2,000 spermatozoon analyzed for each chromosome

2 independent evaluators work on every case

Results compared with internal control to assure highest reliability

Results in two weeks

Are you interested?

Request information Or Email us at infocanada@igenomix.com
Overview
  • SAT
  • Benefits
  • Indications

What is SAT test?

  • The Sperm Aneuploidy Test (SAT) is a diagnostic test to study the genetic etiology of male infertility.
  • It allows for the evaluation of the presence of an abnormal number of chromosomes (aneuploidy and diploidy) in the sperm.

It analyzes the chromosomes that are frequently implicated in spontaneous miscarriages and the chromosomes that can lead to children affected with syndromes, like Down syndrome.  (chromosomes 13, 18, 21,  X and Y).

What is the procedure?

Why use SAT test?

Men with an abnormal SAT result conception may be impacted on three levels: 

EMBRYO LEVEL:

  • Spermatozoa with sex chromosome abnormalities or abnormalities in chromosome 13, 18, or 21 would result in an aneuploid embryo which would have a reduced potential to implant.    

Diploid sperm result in triploid embryos.Rodrigo et al., 2010. 

PREGNANCY LEVEL:

  • An altered SAT result implicates a decreased pregnancy rate after ICSI and increased miscarriage rate. 

Rubio et al., 2001. 

OFFSPRING LEVEL:

  • An altered SAT result implicates an increased risk for offspring with chromosomal imbalances (For example: Down syndrome, Klinefelter syndrome or Turner’s syndrome) 

Who should use SAT test?

  • Men with a low sperm concentration have a higher incidence of sperm chromosome abnormalities.
  • Couples who have suffered recurrent miscarriage of unknown etiology.
  • Couples who have experienced repetitive implantation failure.
  • Couples with a previous pregnancy having chromosomal abnormality.

Test limitations

  • This technique allows the detection of aneuploidy for the limited number of chromosomes included in the test.
  •  In very few ejaculated samples or testicular samples, is there not enough spermatozoa for a proper estimation of the risk of aneuploidy.
Documentation
  • Specialists

Clinical Sheets

Download
Scientific evidence

Relevant related studies:

Rodrigo L, Peinado V, Mateu E, Remohí J, Pellicer A, Simón C, Gil-Salom M, Rubio C. Impact of different patterns of sperm chromosomal abnormalities on the chromosomal constitution of preimplantation embryos. Fertil Steril. 2010 Sep; 94(4):1380-6.

Rubio C, Gil-Salom M, Simón C, Vidal F, Rodrigo L, Mínguez Y, Remohí J, Pellicer A. Incidence of sperm chromosomal abnormalities in a risk population: relationship with sperm quality and ICSI outcome. Hum Reprod. 2001 Oct; 16(10):2084-92. 

Rodrigo L, Mateu E, Mercader A, Cobo A, Peinado V, Milán M, Al-Asmar N, Campos-Galindo I, García-Herrero S, Mir P, Simón C, Rubio C. New tools for embryo selection: comprehensive chromosome screening by array comparative genomic hybridization. BioMed
Research International. 2014; In Press. 

If you´re a little lost with this technical information...

Can we help you?

I’m not a health specialist

Igenomix and fertility

We work to make a world in which infertility is no longer an impossible barrier. Together with clinics and fertility doctors worldwide we investigate human reproduction to change the lives of couples who are trying to conceive.

Other services

PGT-A

Chromosomally normal
embryos selection

More information

ERA

Evaluates the endometrial receptivity

More information

EndomeTRIO

Improve the reproductive prognosis of your patients

More information

Igenomix is in the media

Igenomix is not affiliated with any news outlet or publication identified above. News coverage does not constitute an endorsement of Igenomix or its products.

WE GUIDE YOU

Fertility
Inherited diseases prevention
Healthy pregnancy

OUR SERVICES

Genetic solutions
Learn about genetics

ABOUT US

About Igenomix
Contact
Press and news
Quality
Work with us

FOLLOW IGENOMIX

Blog: Road to fertility

*CAP accreditation applies to the LA lab.

  +1 (905) 565-9495  fax +1 (905) 671-1938
  Email us
  • Argentina
  • Brazil
  • Canada
  • Chile
  • China
  • Colombia
  • Europe
  • France
  • Germany
  • India
  • Italy
  • Japan
  • Korea
  • Mexico
  • Perú
  • Russia
  • Spain
  • Taiwan
  • The Middle East
  • Turkey
  • United Kingdom
  • United States
  • Vietnam
Language

[2019] © Igenomix Privacy policy Quality policy Terms & conditions User Feedback

Request Information


  • reCAPTCHA demo: Simple page

  • We guide you
    • Fertility
    • Healthy Pregnancy
  • Reproductive Health
    • Specialists
      • ERA
      • EndomeTRIO
      • EMMA
      • ALICE
      • CGT
      • PGT-A
      • EMBRACE
      • PGT-M
      • NACE
      • POC
      • SAT
    • Patients
      • ERA
      • EndomeTRIO
      • EMMA
      • ALICE
      • CGT
      • PGT-A
      • EMBRACE
      • PGT-M
      • NACE
      • POC
      • SAT
  • Kit Request
  • About us
    • Igenomix Research
    • About Igenomix
  • Academy
  • Webinars
  • Blog
  • French
  • Canada